Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187447 · ClinicalTrials.gov registry record · Phase 2
Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00187447 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 100 participants.
The verdict
NCT00187447, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if a higher dose of indomethacin will increase the rate of ductus arteriosus closure in extremely premature infants without increasing the side effects. The long term objective is to find the optimal dosing of indomethacin for permanent closure of the Ductus and prevent the morbidity related to PDA and the complications of surgical ligation.
Interventions
- DRUG indomethacin (two different dosing regimens)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-08 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187447
The ClinicalTrials.gov registry entry for NCT00187447 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which indomethacin (two different dosing regimens) is the first listed.
NCT00187447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187447 about?
NCT00187447 is a clinical study titled "Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus". The purpose of this study is to examine if a higher dose of indomethacin will increase the rate of ductus arteriosus closure in extremely premature infants without increasing the side effects. The long term objective is to find the optimal dosing of indomethacin for permanent closure of the Ductus a...
What is the current status of trial NCT00187447?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2003-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00187447?
The interventions under investigation include: indomethacin (two different dosing regimens) (DRUG).
Who is sponsoring clinical trial NCT00187447?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.